EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Effect of Liraglutide on Lung Cancer and Its Potential Protective Effect on High Glucose-Induced Lung Senescence and Oxidative Damage

Zhiyan Pu, Yanxia Yang, Shuanghong Qin, Xiaojuan Li, Can Cui, Weiyu Chen

Frontiers in Bioscience-Landmark · 24.10.2023 · 28 (10)

DOI: 10.31083/j.fbl2810259 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 24.10.2023. Verfasst von Zhiyan Pu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The Second People's Hospital of Gansu Province, Northwest Minzu University, 730000 Lanzhou, Gansu, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Lung Neoplasms. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gansu Province Science and Technology Program Project (2022) - Natural Science Foundation, Central Universities Basic Research Business Fund (2021) - Young Teachers Innovation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lung cancer is a malignant disease with high morbidity and mortality. Lung cancer and diabetes are closely related, and diabetic patients with lung tumors are common in clinical practice. Liraglutide, a glucagon-like peptide-1 receptor (GLP-1R) agonist, is commonly used in the treatment of type 2 diabetes. In this study, we examined the effect of liraglutide on lung cancer and its potential protective effect on high glucose-induced lung aging.

Methods

Indirect mmunofluorescence was done to assess the expression levels of p-AKT, ki67, Caspase3, Bax and PI3K. Western blotting was conducted to determine the expression levels of BAX, BCL2, Caspase9, E-cadherin, N-cadherin, PI3K, AKT and vimentin. Cell viability, cell cycle and cell apoptosis were evaluated by colony formation, CCK-8 assay and flow cytometry. Immunohistochemistry was performed to evaluate the expression of Nf-κb, p15, p16, p21 and SMA in vivo. Besides, a high glucose-induced lung cell injury model was established to evaluate the effect of liraglutide on lung aging and oxidative damage. Sa-β-gal staining was used to assess cellular/ tissue senescence. Cell senescence-related markers (p16, p21 and p53 ) were determined by Western-blot analysis.

Results

The proliferation, cell cycle, migration of lung cancer cells were significantly inhibited after treatment with liraglutide compared to control group (p < 0.05). Furthermore, Liraglutide inhibited the epithelial–mesenchymal transition process of lung cancer cell compared to control group (p < 0.05). Liraglutide also suppressed the proliferation of lung cancer in vivo. Besides, the BEAS-2B cell senescence induced by high glucose was significantly alleviated after treatment with liraglutide compared with control group (p < 0.05). The lung aging and endoplasmic reticulum stress was significantly suppressed after liraglutide treatment.

Conclusions

This work indicates that liraglutide could inhibit lung cancer cell proliferation in vitro and in vivo. In addition, liraglutide exhibited anti-aging effects in vivo and in vivo. The current work has important implications for the treatment of patients with diabetes and lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Lung NeoplasmsHumansLiraglutideProto-Oncogene Proteins c-aktbcl-2-Associated X ProteinOxidative StressLungPhosphatidylinositol 3-KinasesGlucose

Stichwörter der Autor:innen

agingliraglutidelung cancerlung cellsproliferation

Substanzen

LiraglutideProto-Oncogene Proteins c-aktbcl-2-Associated X ProteinPhosphatidylinositol 3-KinasesGlucose

Autor:innen und Institutionen

  • Department of Endocrinology, The Second People's Hospital of Gansu Province, Northwest Minzu University, 730000 Lanzhou, Gansu, China.
  • Department of Endocrinology, Second Affiliated Hospital of Harbin Medical University, 150086 Harbin, Heilongjiang, China.

Förderung

  • Gansu Province Science and Technology Program Project (2022) - Natural Science Foundation
  • Central Universities Basic Research Business Fund (2021) - Young Teachers Innovation Project

Zitieren

APA

Pu, Z., Yang, Y., Qin, S., Li, X., Cui, C., & Chen, W. (2023). The Effect of Liraglutide on Lung Cancer and Its Potential Protective Effect on High Glucose-Induced Lung Senescence and Oxidative Damage. Frontiers in Bioscience-Landmark, 28(10). https://doi.org/10.31083/j.fbl2810259

Vancouver

Pu Z, Yang Y, Qin S, Li X, Cui C, Chen W. The Effect of Liraglutide on Lung Cancer and Its Potential Protective Effect on High Glucose-Induced Lung Senescence and Oxidative Damage. Frontiers in Bioscience-Landmark. 2023;28(10). doi:10.31083/j.fbl2810259

BibTeX
@article{Pu2023,
  author = {Pu, Zhiyan and Yang, Yanxia and Qin, Shuanghong and Li, Xiaojuan and Cui, Can and Chen, Weiyu},
  title = {The Effect of Liraglutide on Lung Cancer and Its Potential Protective Effect on High Glucose-Induced Lung Senescence and Oxidative Damage},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2023},
  volume = {28},
  number = {10},
  doi = {10.31083/j.fbl2810259}
}
Kostenlos starten →